Brandl Talos has advised Graph Therapeutics on a USD 3.1 million pre-seed financing round led by Squareone and Merantix Capital, with participation from NAVEC Investment Management and angel investors, including the Atomico Angel Program. Herbst Kinsky advised NAVEC. Schoenherr advised Squareone. Fladgate reportedly advised the Atomico Angel Program.
Graph Therapeutics is a Vienna company focusing on AI-driven drug discovery for inflammatory and immunological diseases.
The Brandl Talos team included Partner Stephan Strass and Associate Lara Praethaler.
The Herbst Kinsky team included Partner Philipp Kinsky.
The Schoenherr team included Partner Thomas Kulnigg and Attorney at Law Clemens Pretscher.
